Summary
- Major factors influencing the growth of the market.
- Leading players & Top Segments.
- Geographic Overview.
Market growth influenced due to following factors-
- Growing cardiovascular and respiratory diseases,
- Rising adoption of ECMO as a bridge to heart & lung transplantation,
- Growing number of ECMO centers & conferences and training programs to
- Increase awareness, and technological advancements are the significant factors driving the growth of this market
Global market size-
According to the market research report ECMO machine market is expected to reach $ 305.3 Million by 2021, at a CAGR of 4.3%.
Leading Players-
The ECMO machine market was dominated by the Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.). These companies together contributed about 68.8% to the global market in 2015. The other players in the market are XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc. (Germany), and EUROSETS S.r.l. (Italy).
Top Market Segments-
Based on the modality, the ECMO machine market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is estimated to account for the largest share of the global market in 2016, and venoarterial (VA) segment is projected to grow at the highest CAGR in the forecast period.
Based on application, the ECMO machine market is segmented into Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment is estimated to account for the largest share of the market in 2016. The large share of this segment can be attributed to factors such as rising incidence of respiratory failure, lung cancer, and lung transplants, and increasing adoption of ECMO.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654
Geographic Overview -
On the basis of region, the ECMO machine market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America accounted for the largest share of the market, followed by Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is projected to grow at the highest CAGR and serve as a revenue pocket for companies offering ECMO systems.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
[email protected]
According to the market research report ECMO machine market for the forecast period of 2016 to 2021.
This market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654A number of factors such as the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to heart & lung transplantation, growing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements are the significant factors driving the growth of this market.
In addition, the growing aging population and the number of people suffering from cardiopulmonary diseases in populous countries such as India and China are factors that are expected to offer significant growth opportunities for ECMO systems.
On the basis of region, the ECMO machine market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
In 2016, North America accounted for the largest share of the market, followed by Europe, Asia-Pacific, and the Rest of the World.
The Asia-Pacific market is projected to grow at the highest CAGR and serve as a revenue pocket for companies offering ECMO systems.Based on the modality, the ECMO machine market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV).
Extracorporeal membrane oxygenation machine market has been registering increasing revenue as a result of several factors that include increasing use of ECMO machine for open heart surgeries or procedures that involve life threatening cardiovascular and respiratory diseases.
Increasing number of hospitals and other medical facilities have been reported to have ECMO machines.
They are designed to oxygenate blood outside the patient’s body and allows the heart and lungs to rest.
Some of the factors such as chances of bleeding, stroke, infection and kidney failure may hamper the growth of ECMO machine market.
However, in spite of risks, ECMO machines have been known to save lives and are an integral part of heart and lung bypass surgeries which will continue to add to ECMO machine market revenue by 2025.Segmentation:ECMO machine market divides the market on the basis of component, modality, application and region.ECMO machine consists of different components such as pumps, controllers, oxygenators, cannula and accessories.
Due to the expansive use of veno-arterial ECMO machines in case of cardiac collapse, veno-arterial modal segment of ECMO machine market is expected to hold a major market share while increasing cases of cardiac shock is expected to help in the fast growth of veno-venous modal segment in the coming years.ECMO machine market has several application segmentations which include respiratory, cardiac and extracorporeal cardiopulmonary resuscitation.
Extracorporeal Membrane Oxygenation Machine Market Research Report: Information by Component (Pumps, Oxygenators, Cannula and others), Modality, Application and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2027Market HighlightsIt is estimated that the global extracorporeal membrane oxygenation machine market is expected to register a CAGR of 4.8 % during the forecast period of 2019 to 2025, with a market value of USD 267.60 million in 2018.Extracorporeal membrane oxygenation machine is also known as a life support machine.
The main function of extracorporeal membrane oxygenation machine is to provide enough oxygen to the body when heart and lung are not functioning properly.
However, the high cost of surgery and increasing side effect after the treatment is expected to curb the growth of the extracorporeal membrane oxygenation machine market.The global extracorporeal membrane oxygenation machine market is currently dominated by several market players.
The key players are involved in new product launches and strategic collaborations to strengthen its market position.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8119SegmentationThe global extracorporeal membrane oxygenation machine market has been segmented based on component, modality, and application.The market, based on component, has been divided into pumps, oxygenators, controllers, cannula, and accessories.
The veno-arterial segment is expected to hold a major share in the market due to its widespread use in the treatment of cardiovascular collapse.
The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the extracorporeal cardiopulmonary resuscitation segment is expected to be the fastest-growing due to the rising incidence of cardiac illness worldwide.Key PlayersSome of the key players in the global extracorporeal membrane oxygenation machine market are Getinge Group, Medtronic, Livanova PLC, Abbott, Agilent Technologies, Siemens AG, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, Microport Scientific Corporation, Nipro Corporation, ALung Technologies, Inc., MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Terumo Cardiovascular Systems Corp, and Others.Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
